Menu
Community-based HIV prevalence in KwaZulu-Natal, South Africa: results of a cross-sectional household survey.

Kharsany ABM, Cawood C, Khanyile D, Lewis L, Grobler A, Puren A, Govender K, George G, Beckett S, Samsunder N, Madurai S, Toledo C, Chipeta Z, Glenshaw M, Hersey S, Abdool Karim Q.
Lancet HIV 2018 July. doi: 10.1016/S2352-3018(18)30104-8.

Read publication
Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death.

Jackson L, Hunter J, Cele S, Ferreira IM, Young AC, Karim F, Madansein R, Dullabh KJ, Chen CY, Buckels NJ, Ganga Y, Khan K, Boulle M, Lustig G, Neher RA, Sigal A.
eLife 2018; 7:e30134. doi: 10.7554/eLife.30134

Read publication
Vaginal microbes, inflammation, and HIV risk in African women.

Passmore J-AS, Jaspan HB.
Lancet Infectious Diseases 2018; 18(5):483-484.

Read publication
Identifying 'corridors of HIV transmission' in a severely affected rural South African population: a case for a shift toward targeted prevention strategies.

Tanser F, Bärnighausen T, Dobra A, Sartorius B.
International Journal of Epidemiology 2018; 47(2):537-549.

Read publication
Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV.

Barnabas SL, Dabee S, Passmore JS, Jaspan HB, Lewis DA, Jaumdally SZ, Gamieldien H, Masson L, Muller E, Maseko VD, Mkhize N, Mbulawa Z, Williamson AL, Gray CM, Hope TJ, Chiodi F, Dietrich J, Gray G, Bekker LG; Women’s Initiative in Sexual Health (WISH) study team.
International Journal of STD & AIDS 2018; 29(6):531-539.

Read publication
High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.

Mbulawa ZZ, van Schalkwyk C, Hu NC, Meiring TL, Barnabas S, Dabee S, Jaspan H, Kriek JM, Jaumdally SZ, Muller E, Bekker LG, Lewis DA, Dietrich J, Gray G, Passmore JS, Williamson AL.
PLoS One 2018; 13(1):e0190166.

Read publication

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.